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Summary 
Little is known  about how mononuclear phagocytes (MP)  are cleared from sites of inflamma- 
tion as inflammatory lesions resolve. In this study, the possibility that MP could be cleared from 
tissues by migrating across endothelium  in the basal to apical direction was investigated.  In an 
in  vitro  model  of a  blood  vessel  wall  consisting  of human  umbilical  vein  endothelial  cells 
(HUVEC) grown on amniotic tissue, a majority of MP that initially transmigrated into the am- 
nion later exited by migrating back across the endothelium in the basal to apical direction.  MP 
that  egressed  from  these  cultures  adhered  to  the  apical  surface  of the  endothelium  or  were 
found  nonadherent  in  the  medium  above  the  endothehum.  Egression  of MP  continued 
throughout the 4-d period examined, displaying higher than first order kinetics and a tl/2 of ap- 
proximately 24 h. These kinetics were decreased by increasing the volume of medium bathing 
the  cultures,  suggesting that a soluble factor(s)  regulates  the  rate of egression.  In contrast,  the 
kinetics were accelerated by pretreating the endothelium with IL-1. The initial phase of this in- 
creased  rate  of egression  was  inhibited  by  antibodies  to  intercellular  adhesion  molecule  1 
(ICAM-1) or CD18 by 100 and 71%, respectively. Immunostaining revealed that ICAM-1 was 
present  on  the  apical  and  basal  surfaces  of umbilical  vein  endothelium  in  vitro  and  in  situ. 
These data demonstrate that MP can traverse endothelium  in the basal to apical direction,  and 
lend insight into the mechanisms by which this process occurs. 
M 
"  ononuclear phagocytes (MP) 1 are found ubiquitously 
dn  animal  tissues.  Derived  from bone  marrow  pre- 
cursors,  they  first  circulate  in  the  blood  where  they  are 
known  as  monocytes.  When  monocytes  traverse  the  en- 
dothelial hning of blood vessels to enter tissues, they differ- 
entiate  into  macrophages  (1).  During  inflammation,  accu- 
mulation of MP at the affected site usually increases greatly 
above the steady state level (2, 3).  Once  localized to a site 
of inflammation, MP phagocytize infectious organisms and 
damaged  tissue  debris,  act  as  APCs,  and  secrete  a  large 
number  of immunoregulatory  molecules  (4).  In  conjunc- 
tion  with  the  resolution  of an  inflammatory  lesion,  the 
density of MP  in the affected tissue declines  over a period 
of several days (3, 5, 6). However, little is known about the 
mechanisms by which accumulated MP are removed from 
tissues. 
1Abbreviations used in this paper: HUVEC, human umbilical vein endothe- 
lial cells; ICAM-1, intercellular adhesion molecule 1; IL-lra, IL-1 recep- 
tor antagonist; M199, Medium 199; MCP-1, monocyte chemoattractant 
protein  1;  MP,  mononuclear  phagocytes;  RT,  room  temperature; 
VCAM-1, vascular cell adhesion molecule 1. 
Three means for clearance of MP from tissues have been 
suggested  in  different  experimental  models:  (a)  exit  via 
lymphatic vessels;  (b)  death in situ  and subsequent  engulf- 
ment by other macrophages;  and  (c) egression from tissues 
by  reentrance  into  the  bloodstream.  With  respect  to  the 
first of these mechanisms,  it has been clearly demonstrated 
that MP  can exit connective tissue  (7)  or pulmonary tissue 
(8,  9)  through  draining  lymphatic  vessels,  but  only  0.1- 
0.2%  of MP  that  accumulate  within  the  lung  use  such  a 
route  (8).  Second,  phagocytic  engulfment  by  MP  is 
thought to be a major mode of clearance for apoptotic neu- 
trophils  (10),  but phagocytosis  of one  MP  by another  has 
yet  to  be  described  in  vivo.  Apoptosis  of MP  in  situ  has 
been observed in atherosclerosis  (11,  12). In contrast,  some 
monocyte-derived foam cells seem to be cleared from ath- 
erosclerotic lesions by migrating across endothelium  in the 
ablumenal  to lumenal  direction  and consequently  reenter- 
ing  the  bloodstream  (13-15).  Whether  MP  other  than 
lipid-laden foam cells are actually capable of traversing en- 
dothelium  in the basal to apical direction  has not been de- 
termined.  Thus,  the relevance of such a mechanism under 
steady state or other inflammatory conditions is unknown. 
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has become generally accepted that, once extravasated, MP 
cannot recirculate (16). However, we are not aware of any 
data that confirm this premise. In the present study, we ex- 
plored  whether  human  MP  migrate  across  endothelial 
monolayers in  the  basal  to  apical  direction in  vitro.  For 
these investigations, a well-characterized model of a blood 
vessel wall that consists of human umbilical vein endothe- 
lial cells (HUVEC) grown on human amniotic connective 
tissue was employed (17). In these experiments, MP did in- 
deed traverse endothelium in the basal to apical direction. 
An analysis of how  this phenomenon was  regulated indi- 
cated that egression of MP from HUVEC/amnion cultures 
is not a completely random process, since its kinetics could 
be altered by cytokines or by dilution. Further studies are 
presented that indicate that MP use CDll/CD18  to bind 
to  endothelial intercellular adhesion molecule I(ICAM-1) 
as they migrate across the endothelium in the basal to apical 
direction. 
Materials  and Methods 
Isolation and Culture of Cells.  HUVEC/amnion cultures  were 
prepared  as previously described  (17). In brief,  amniotic mem- 
branes from human placentas (obtained from normal deliveries at 
University Hospital,  State University of New York  [SUNY]  at 
Stony Brook)  were  fastened  to  Teflon rings  (SUN3(  at  Stony 
Brook Machine Shop) and held in place by a Viton O-ring (C. E. 
Conover & Co., Inc., Fairfield, NJ),  forming a well-like culture 
chamber.  Individual chambers  were  soaked  in  1.7% NH4OH 
(vol/vol), and the bottom surface was scraped with a rubber po- 
liceman to remove the amniotic epithelium. The resultant acellu- 
lar amniotic connective tissue consists predominantly of collagen 
types I and III (18). The thickness of amniotic tissues used aver- 
ated  "~  I~m, ranging from about 40 to  130  p~m. Endothelial 
cells isolated from human umbilical veins (collected at St. Charles 
Hospital,  Port Jefferson,  NY)  (19) or human microvascular  en- 
dothelial cells given by Dr. Marcia G. Tonnesen (SUNY at Stony 
Brook)  were seeded on the stromal surface of prepared amniotic 
tissue at  second or sixth  passage, respectively.  Endothelial cell- 
amnion cultures were used in transmigration assays 7-10 d later. 
HUVEC/amnion  cultures  were  maintained  in  Medium  199 
(M199)  (GIBCO BILL, Gaithersburg,  MD) containing 20% fetal 
bovine serum (FBS) (HyClone Laboratories,  Inc., Logan,  UT), 
100 U/ml of penicillin, 100 p.g/ml of streptomycin, and 2 b~g/ml 
of amphotericin B (GIBCO BILL). Only serum having undetect- 
able levels ofendotoxin, as reported by the manufacturer, was used. 
We  tested  the  serum further to  ensure that it did not activate 
transendothelial  migration ofneutrophils (see below and Results). 
Human monocytes were isolated to greater than 90% purity by 
density gradient centrifugation in a hyperosmotic medium (Accu- 
denz; Accurate  Chemical Co., Westbury, NY) according to the 
method of Meerschaert  and Furie (20), and neutrophils were iso- 
lated by centrifugation of leukocyte-rich  plasma in Ficoll-Hypaque 
as described by Anderson et al. (21). 
Transmigration Assay.  Isolated  monocytes  were  resuspended 
in M199 containing 20% heat-inactivated FBS~ and transmigra- 
tion assays were initiated by application  of 2  ￿  10  s monocytes/ 
cm  2 to the apical side of HUVEC/amnion cultures that were ei- 
ther pretreated with 5 U/ml of IL-l[3 (Collaborative  Biomedical 
Products,  Bedford, MA) for 4 h or left untreated. Cultures treated 
with IL-1 were rinsed twice in M199 before  addition ofmono- 
cytes. Three to five cultures were used for each experimental pa- 
rameter.  HUVEC/amnion cultures  incubated for more than 2 h 
with MP were rinsed after 2 h of incubation by sequential passage 
through three beakers containing M199 (100 ml each). Medium 
with or without Abs was then added to the interior of the cul- 
tures  (apical compartment) and beneath the  cultures  for  further 
incubation. For experiments using Abs, rinsed HUVEC/amnion 
cultures  containing transmigrated  MP  (2-h cultures)  were  posi- 
tioned on silicone rubber supports glued to the bottom of 12-well 
culture dishes  (22) before the  addition of mediunl to  the  basal 
compartment. This step  to elevate  the cultures  was included to 
maximize the access of antibodies to the basal aspect of the endo- 
thelium. 
After incubation at 37~  for the desired duration, the cultures 
were fixed in 10% formalin. Fixed cultures were rinsed in saline, 
cut  from  the  Teflon ring with  a  cork-borer,  and stained  with 
modified Wright's stain.  To  quantitate the  percentage  of MP 
added that became associated with the cultures,  stained  cultures 
were viewed en face microscopically  and the number of MP in 
nine ￿  fields per tissue was counted. Cross sections (2.2 bun) 
of each  culture,  embedded  in  block  molds  of JB-4  polymer 
(Polysciences,  Inc., Warrington, PA),  were  examined to  deter- 
mine the percentage  of associated monocytes that had  migrated 
beneath the HUVEC monolayer. These values were corrected to 
account for  detachment during the  embedding process  of MP 
that  were adherent to the apical surface of the endothelium, as 
previously described (23). 
For transmigration studies using neutrophils, neutrophils were 
incubated with HUVEC/amnion cultures  (5  ￿  10  s neutrophils/ 
cm  2) for 20 rain at 37~  HUVEC were pretreated with medimn 
conditioned by MP/HUVEC cocultures  or freshly prepared me- 
dium for 4 h and washed  in M199 before  application of neutro- 
phils.  In other experiments measuring transmigration of neutro- 
phils,  unstimulated HUVEC/amnion cultures  were  elevated  on 
silicone rubber supports glued to the bottom of wells in a 12-well 
plate, and 10 -7 M FMLP (Peninsula Laboratories,  Inc., Behnont, 
CA)  was added to the basal compartment (24). Quantitation of 
transmigration was determined as for MP. 
Abs  and  Recombinant  Proteins.  The  hybridoma  producing 
TS1/18 mAb against CD18 (IgG1)  (24) was purchased  from the 
American Type  Culture  Collection  (Rockville,  MD).  Hybri- 
doma cells were injected into the peritoneum of pristane-primed 
BALB/c retired breeder mice. IgG in the ascitic fluid was purified 
according to  the  method of Harlow and Lane  (25) except that 
protein G-Sepharose (Pierce  Chemical Co.,  Rockford,  IL)  was 
substituted for protein A-Sepharose to  maximize absorption of 
mouse IgG1  (26). IgG from ascites containing mAb MOPC31c 
(Sigma  Chemical Co.,  St.  Louis,  MO),  an  IgG1  of unknown 
specificity, was purified by the same protocol. Fab fragments  of 
these  and other Abs used were prepared  by incubating purified, 
intact IgG with Sepharose-immobilized papain (Pierce). The di- 
gested  material  was  applied  to  a  protein A-Sepharose  (Pierce) 
column to remove Fc fragments and nondigested Ig. The quality 
of purification and efficiency of Ig fragmentation were analyzed 
by SDS-PAGE.  Purified Fab  fragments  were  quantitated using 
the  bicinchoninic acid  protein assay (Pierce).  Fab  fragments  of 
TS1/18 and MOPC31c were used in transmigration assays at 40 
~zg/ml. 
A neutralizing mAb against ICAM-1, 17,6.5 (IgG2a) (27), was 
generously provided by Drs. C. Wayne Smith (Baylor College of 
Medicine, Houston, TX) and Robert ILothlein (Boehringer In- 
gelheim Corp.,  Ridgefield,  CT).  Fab  fragments  of R6.5  were 
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For immunostaining, intact R6.5 mAb was used at 20 p.g/ml. As 
an  immunostaining  control,  UPC10  (IgG2a),  an  anti-[3-2-6-- 
linked fructosan Ab, was purchased from  Sigma Chemical Co. 
and used at 20 ~g/ml. F(ab')2 fragments ofH18/7, a neutralizing 
mAb against E-selectin (28), were kindly given to us by Dr. Fran- 
cis  W.  Luscinskas  (Brigham  and  Women's  Hospital,  Boston, 
MA) and were used in transmigration experiments at 20 ~g/ml. 
Immunostaining for E-selectin was done using a  1 : 200 dilution 
of rabbit polyclonal antiserum against human recombinant soluble 
E-selectin.  Distribution  of vascular  cell  adhesion  molecule  1 
(VCAM-1)  on  endothelium  was  investigated using  an  immu- 
nopurified polyclonal Ab against soluble, recombinant VCAM-1 
at 20 p.g/ml. For transmigration assays, Fab fragments of the neu- 
tralizing mAb against VCAM-1 4B9 were used at 20 b~g/ml (29). 
These Abs to E-selectin and VCAM-1 were the generous gift of 
Dr.  Roy Lobb  (Biogen Inc.,  Cambridge,  MA).  For immuno- 
staining  controls,  normal  rabbit  serum,  obtained  from  Sigma 
Chemical Co., was used at equivalent IgG concentrations as these 
Abs. $101, a neutralizing mAb to monocyte chemoattractant pro- 
tein 1 (MCP-1)  (23),  was purchased from Anogen (Mississauga, 
ON, Canada), digested to Fab fragments, and used in experiments 
at 20 ~g/ml. Ab fragments ofmAb TS1/18,  MOPC31c,  R6.5, 
H18/7,  4B9, and $101  were tested for endotoxin using a chro- 
mogenic  limulus  amebocyte  lysate  assay  (BioWhittaker,  Inc., 
Walkersville, MD). When specified, Fab fragments prepared from 
neutralizing antibodies to TNF-~x (R&D Systems, Inc., Minneap- 
olis, MN) were added to HUVEC/amnion cultures at 20 p.g/ml, 
in combination with 100 ng/ml of recombinant human IL-1 re- 
ceptor  antagonist  (IL-lra)  (R&D  Systems,  Inc.).  Recombinant 
human MCP-1 and a sandwich ELISA kit to detect human IL-113 
were also purchased from R&D Systems, Inc. 
Immunostaining.  To  immunostain for adhesion molecules in 
HUVEC/amrfion  cultures,  cultures were  fixed in  freshly pre- 
pared,  neutralized,  phosphate-buffered  3%  paraformaldehyde 
(Sigma Chemical Co.) for 1 h at 4~  and then rinsed in PBS. Be- 
fore application of Abs, cultures were incubated with PBS con- 
taining 0.2%  BSA  (Sigma Chemical Co.)  for  30  rain  at  room 
temperature (RT).  Then dilutions of the antiadhesion molecule 
Abs were applied to the cultures for 2  h  at RT.  Subsequently, 
cultures were rinsed in PBS and then washed for 1-12 h  in 500 
ml of gently stirred PBS at 4~  TP,  ITC-conjugated goat anti- 
mouse  or  anti-rabbit IgG  (Organon  Teknika  Corp.,  Durham, 
NC) was added to the cultures at 8 btg/ml for 1 h at R.T. Finally, 
the cultures were washed in PBS  as described in the preceding 
step. The tissues were cut from the Teflon ring with a cork-borer 
and embedded inJB-4 polymer for cross sectional examination. 
To  immunostain  for  adhesion molecules in  intact  umbilical 
veins, the central vein of umbilical cords was cannulated, perfused 
with M199 containing 20% heat-inactivated FBS with or without 
5 U  IL-1/ml, and incubated at 37~  for 4 h  (for E-selectin im- 
munostaining) or 18 h (for ICAM-1 and VCAM-1 immunostain- 
ing). Umbilical veins were then perfused with PBS containing 3% 
paraformaldehyde and incubated for 30 min at P,T to fix the vein 
in a distended position. Finally, the entire umbilical cord was im- 
mersed in the fixative solution for an additional 30 re_in. The tis- 
sue was rinsed in PBS and cut into thin slices ("-'3 mm) with a ra- 
zor blade. Immunostaining was then carried out as just described. 
This  procedure  was  performed  using umbilical cords  obtained 
within 2 h of delivery. 
Chemotaxis Assay.  Solutions  of  conditioned  medium  from 
MP/HUVEC  cocultures, containing or lacking Fab fragments to 
MCP-1,  were  placed in the  lower compartment  of blind well 
chambers (Neuroprobe, Inc., Cabin John, MD).  Freshly isolated 
monocytes were resuspended in M199 containing 20% heat-inac- 
tivated FBS and were placed in the upper compartment of the 
chambers, which was separated from the lower compartment by a 
cellulose nitrate  filter with  5.0-btm  pores  (Neuroprobe,  Inc.). 
The  chambers  were  incubated for  90  min  at  37~  and  filters 
were fixed, stained, and analyzed as previously described (23). 
Statistics.  The percentages of MP beneath the endothelium in 
experimental conditions and controls were  compared using the 
two-tailed Student's t test. Data from different experiments were 
normalized before comparison by setting the  highest value  for 
percentage  of  MP  located  beneath  the  HUVEC  monolayer 
within each experiment equal to 1.0 and calculating relative val- 
ues for the remaining data. 
Results 
MP Egress from a Tissue Substrate  by Migrating across Endo- 
thelium in the Basal to Apical Direction.  Previous work from 
this laboratory has demonstrated that isolated human mono- 
cytes traverse unstimulated HUVEC  monolayers grown on 
amniotic tissue (20). Maximal transmigration ofmonocytes 
is reached after 2  h,  when  ~40%  of monocytes added to 
HUVEC/amnion  cultures  have  crossed  the  endothelium 
and are located within the amniotic tissue. Most of the re- 
maining  60%  of monocytes  do  not  attach  to  the  endo- 
thelium at all. That is, >95% ofmonocytes that bind to the 
apical surface subsequently migrate into the underlying am- 
nion.  After traversing the  endothelium,  MP  migrate  to  a 
variety  of depths  within  the  amnion,  but  none  migrates 
deeper  than  about  two  thirds  of the  amnion's  thickness. 
Because  monocytes likely begin  differentiation into  mac- 
rophages immediately after transendothelial migration, we 
refer to transmigrated monocytes as MP. 
To evaluate whether MP  that had entered the amniotic 
tissue might later exit by migrating back across the  endo- 
thelium,  we  performed  extended  time  courses  in  which 
MP  were  incubated  with  HUVEC/amnion  cultures  for 
more than 2  h.  In these experiments, monocytes were first 
incubated with HUVEC/amnion  cultures for 2 h. Cultures 
were  then rinsed to  remove nonadherent  monocytes, and 
fresh medium was added for further incubation. Relative to 
2  h  of incubation,  there  were  fewer  MP  associated with 
HUVEC/amnion  cultures  after  12  or 24  h  of incubation 
(Fig. 1). Nonadherent MP could be collected from the api- 
cal compartment  of the  cultures at these later times.  Fur- 
thermore,  a  large  fraction  of MP  that  remained associated 
with HUVEC/amnion  cultures at  12  or 24  h  were  found 
adherent to the apical surface of the endothelium.  Indeed, 
only 66 or 49% of MP that were beneath the endothelium 
at 2  h  of incubation remained there after 12 or 24 h  of in- 
cubation, respectively (Fig. 1).  These data demonstrate that 
monocytes exited from amniotic connective tissue by mi- 
grating across endothelium in the basal to apical direction. 
Once egressed, MP remained adherent to the apical surface 
of the  endothelium  for some period of time and  then  fi- 
nally detached  (data  not  shown).  It is interesting to  note 
that  MP  within  the  amnion  were  found  at  a  variety  of 
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cultures  were  next  studied in  detail.  Egression continued 
throughout the 4-d period examined, albeit relatively slowly 
after the first 24 h, displaying higher than first order kinet- 
ics and a  h/2 of"~24 h  (Fig. 2). Analysis of some of the cul- 
tures by trypan blue exclusion revealed that  >95%  of MP 
and  HUVEC  were viable  during the  4-d  assay.  MP  that 
remained within amniotic tissue for at least 48-72 h  under- 
went pronounced morphological changes, acquiring a fusi- 
form shape and increasing in size (Fig.  3).  These morpho- 
logical  changes  most  likely  resulted  from  their  ongoing 
Figure 1.  Extended incubation of  MP with HUVEC/amnion cultures. 
MP were incubated with unstimulated HUVEC/amnion cultures for 2 h. 
After this time, some of the cultures were fixed for analysis of transmigra- 
tion; other cultures were rinsed thoroughly to remove nonadherent MP, 
and fresh medium was added for an additional 10 or 22 h of incubation. 
Total height of the bars represents the percentage of MP added that were 
associated with the cultures after fixation. Patterned  portions  of the bars 
correspond to the percentages of  added MP that migrated beneath the en- 
dothelium,  and open portions  of the bars indicate the percentage of MP 
found adherent  to the endothelial apical surface. Plotted values represent 
the mean -+ SD of triphcate cultures from 2 (for 12 h data) to 10 (for 24 h 
data) independent experiments.  SDs for values indicating the percentage 
of MP associated with HUVEC/amnion cultures  are shown by dotted 
lines (positive direction  only).  SDs for values indicating  the percentage 
of MP located beneath the HUVEC monolayer are depicted by solid lines 
(negative direction  only). Differences in the numbers of MP beneath the 
endotbelium at 2 h versus 12 or 24 h of  incubation are statistically signifi- 
cant, p  <0.001.  The differences in the total numbers  of MP associated 
with the cultures (total height of the bar) at 2 h versus 12 or 24 h are not 
significant. 
depths, even as some were leaving the cultures. Similar re- 
sults  as  shown  in  Fig.  1  were  obtained  when  MP  were 
coincubated  with  human  microvascular  endothelial  cells 
grown on amnion (not shown). 
The kinetics of egression of MP from HUVEC/amnion 
100 
E 
10 
0  24  48  72  96 
Time  (h) 
Figure 2.  Time course of MP retention in amniotic connective tissue. 
HUVEC/amnion cultures were incubated with MP for 2 h, rinsed, and 
fixed or further  incubated  for an additional 2-94 h. Cultures  incubated 
longer than a total of  24 h were rinsed thoroughly  at each 24 h interval to 
remove nonadherent MP from the apical compartment of the cultures. 
Data were normalized by setting the values obtained at 2 h of incubation 
(when there was a maximal number of  MP beneath HUVEC) in each ex- 
periment equal to 100% and calculating relative values for the remaining 
data. Data are combined from five experiments performed in triplicate, r 
for logarithmic fit of curve =  0.98. 
Figure 3.  Micrographs ofMP/HUVEC cocultures viewed en face. (a) 
The morphology of MP incubated for 2 h with HUVEC grown on hu- 
man anmiotic connective  tissue; the MP have just completed their trans- 
migration  beneath the  endothelium.  (b)  The  typical morphology of a 
MP-HUVEC coculture after 72 h of incubation.  (Arrows) Representative 
MP. (Arrowheads) Faintly apparent endothelial cell nuclei. Bar, 30 ~m. 
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gressed beyond the time when these morphological changes 
occurred,  these data suggest that  differentiation into mac- 
rophages  may  not  abrogate  the  potential  of MP  to  exit 
connective  tissue by migrating across endothelium  in  the 
basal to apical direction. 
IL-I  Increases the  Initial  Rate  of  Egression  of MP from 
HUVEC/Amnion  Cultures.  IL-113  is  a  proinflammatory 
cytokine that acts on endothelial cells to upregulate adhe- 
sion  molecules  and  chemoattractants  for  leukocytes  (30). 
We, therefore, investigated the effect of IL-1 on egression 
of MP  from  HUVEC/amnion  cultures.  Previous  studies 
have  shown  that  IL-1  does  not  increase  the  extent  of 
monocytic  transmigration  across  HUVEC  monolayers  in 
the apical to basal direction, though  it does accelerate the 
kinetics of their  adhesion  (20).  Pretreatment  of HUVEC 
with  IL-1  increased the rate at which monocytes egressed 
from the cultures (Fig. 4). The increased kinetics caused by 
IL-1 were apparent only in the first few hours of the assay; 
after 4  h  of incubation,  the  rate  of exodus was  similar in 
IL-l-treated and untreated cultures. 
Because MP are primary sources ofproinflammatory cy- 
tokines such as IL-1 in vivo (31), it was important to deter- 
mine  whether  MP  that  migrated  across  unstimulated 
HUVEC/amnion  cultures  produced  IL-1  or  other  cyto- 
kines with similar proinflammatory activity (such as TNF-o  0, 
which  in  turn  might  act on  the  endothehum  to promote 
egression of MP from the cultures.  To detect the biologic 
activity of proinflammatory cytokines, an  assay measuring 
transmigration  of PMN  was  used.  PMN  incubated  with 
HUVEC/amnion cultures migrate across endothehal mono- 
layers pretreated with  IL-1  or TNF-c~ but  not  across un- 
stimulated HUVEC  (32).  In this assay, PMN  were stimu- 
lated  to  transmigrate  across  HUVEC  pretreated  with 
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Figure 4.  Effect  of IL-1 on exit of MP from HUVEC/arrmion  cul- 
tures. MP were incubated for 2 h with untreated HUVEC/amnion  cul- 
tures (open symbols) or HUVEC/amnion cultures that had been pretreated 
with IL-I for 4 h (filled symbols). Cultures were then fixed or rinsed thor- 
oughly  in M199  and further  incubated  for 2-10 h.  Data plotted are 
derived from a single experiment performed in triplicate. Data were nor- 
mahzed as in Fig. 2. The percentage ofmonocytes that transmigrated into 
unstimulated or IL-l-stimulated HUVEC/amnion  cultures at 2 h of incu- 
bation was 5l + 4% and 45 •  6%, respectively.  The comparison at 4 h of 
incubation in this experiment was repeated five times with similar results. 
conditioned medium  from  MP/HUVEC  cocultures  (Fig. 
5), indicating that proinflammatory cytokines are indeed pro- 
duced by MP/HUVEC  cocultures. A  sandwich ELISA con- 
firmed the presence oflL-1 in the cultures at levels that ranged 
from 7 to 96 pg/ml in the conditioned media collected. 
The production ofproinflammatory cytokines by cocul- 
tures  of MP  and HUVEC  raised the  question  of whether 
egression could occur in the absence of cytokine stimula- 
tion of the endothehum.  Perhaps basal to apical transendo- 
thelial migration  of MP  is  a  cytokine-dependent  process 
and occurs at a later time in the initially unstimulated cul- 
tures, relative to cultures pretreated with IL-1, because of a 
delay in the synthesis oflL-1 or TNF-ee in situ by the MP. 
To assess the requirement for stimulation by cytokines, we 
incubated  MP/HUVEC  cocultures  for  13  h  in  the  pres- 
ence of neutralizing anti-TNF-ot Fab fragments and IL-lra, 
which prevents binding oflL-1 to IL-1 receptors (31). The 
extent of exit of MP from HUVEC/amnion  cultures in the 
presence  of these  inhibitors  was  not  different  than  from 
cultures lacking the inhibitors (Fig. 5).  To  be  certain that 
endothelial activation was  inhibited in  these  experiments, 
subsequent  control  experiments  measuring  transmigration 
of PMN  were  performed  (Fig.  5).  In  these  experiments, 
fresh  HUVEC/anmion  cultures  were  pretreated  for  4  h 
with medium collected from MP/HUVEC  cocultures that 
had been assayed for egression in the presence or absence of 
IL-lra and anti-TNF-er Fab fragments. The levels oflL-lra 
and  anti-TNF-~x Ab fragments  that  remained in  medium 
collected at the end of the egression experiments substan- 
tially reduced  activation  of the  endothehum.  Specifically, 
transmigration of neutrophils was  82%  lower in  HUVEC 
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Figure 5.  Role of endogenous IL-1 and TNFqx in egression of MP 
from HUVEC/amnion  cultures. MP were added to initially unstimulated 
HUVEC/amnion  cultures in the presence or absence of IL-lra and neu- 
tralizing anti-TNF-cx Fab fragments and incubated for  13  h.  Cultures 
fixed at this time were analyzed to determine the extent of MP exodus in 
the presence or absence of the cytokine inhibitors (stippled bars). Media 
collected from the MP/HUVEC cocultures at the end of the 13-h assay 
or fresh medium  were  incubated with  unstimulated HUVEC/amnion 
cultures for 4 h, and PMN were subsequently added to the cultures to 
measure their transmigration (striped bars). In HUVEC/amnion cultures 
preincubated with  fresh medium,  0.5  +  0.5% of PMN transmigrated. 
Data represent the mean + SD of  one experiment performed in triplicate. 
The experiment was repeated with similar results. 
455  Randolph and Furie cultures  pretreated  with  MP/HUVEC  conditioned  me- 
dium  containing  the  cytokine  inhibitors  than  in  cultures 
pretreated  with  medium  collected  from  MP/HUVEC 
cocultures lacking cytokine inhibitors (Fig. 5). Since emer- 
gence of MP from HUVEC/amnion  cultures was not sup- 
pressed in the  continuous presence  of inhibitors of endo- 
thelial activation, basal to apical transendothelial migration 
does not  seem to require  cytokine stimulation of the  en- 
dothelium.  However,  we  cannot  eliminate the  possibility 
that low, residual levels of proinflammato~ cytokine activ- 
ity mediate exodus of MP from HUVEC/amnion  cultures. 
Experiments  using  IL-lra  and  anti-TNF-cx  Fab  frag- 
ments  alone or in combination revealed that  the  majority 
of proinflammatory cytokine activity that  accumulated  in 
MP/HUVEC  cocultures  was  IL-I~  (data  not  shown). 
Analyses of media collected from MP  cultured for 24 h  in 
amnion alone or under nonadherent conditions in a Teflon 
beaker delineated the step at which MP were stimulated to 
produce IL-1. A  sandwich ELISA did not detect IL-113 in 
24-h  conditioned medium  derived from  MP  adherent  to 
tissue culture plastic or cultured under nonadherent condi- 
tions, but  such  activity was  present  in  medium  from  MP 
cultured  with  amnion  lacking  endothelium  (data  not 
shown). Because only some of these conditions resulted in 
production ofproinflammatory cytokines, secretion of lL-1 
by MP is apparently not a direct consequence of the proce- 
dure used for their isolation. Collagen, in the presence of 
fibronectin,  stimulates  secretion  of IL-1  by  MP  in  vitro 
(33), potentially explaining these findings. 
Dilution Decreases the Rate of MP Exit from HUVEC/Am- 
nion Cultures.  If egression  of MP  has  physiological rele- 
vance, the phenomenon should persist under nonstatic, di- 
luting conditions, as would be found in flowing blood. To 
investigate this possibility, MP were first allowed to migrate 
for 2  h  across HUVEC  grown  on amnion.  Then the cul- 
tures were pierced with a stainless steel hook that was sub- 
sequently suspended in a beaker containing 0.5-1.0 liters of 
culture  medium and incubated for 22  or 46  h  more with 
gentle stirring. Cultures to be incubated for a total of 48 h 
were  transferred  to  a  beaker  containing  0.5-1.0  liters  of 
fresh medium  at 24  h  of incubation. These  particulars are 
hereafter denoted as "large volume" conditions. For com- 
parison,  MP  were  incubated with  HUVEC/amnion  cul- 
tures held under the static, smaller volume conditions used 
in previous experiments (0.5 rnl of medium in the interior 
of the cultures, 1.0 ml of medium surrounding the exterior 
of the cultures). Such cultures are henceforth stated to have 
been incubated under "small volume" conditions. The num- 
ber of MP  located within the amniotic matrix of cultures 
subjected to large volume conditions diminished with time 
of incubation,  but  this decrease  occurred with  slower ki- 
netics than in the small volume controls (Fig. 6), increasing 
the tl/2 ofegression to ~"48 h. By 48 h, the extent of loss in 
small  and  large  volumes  was  similar.  As  in  unstimulated 
cultures, the kinetics of egression in HUVEC/amnion  cul- 
tures  pretreated with  IL-1  were  markedly reduced  under 
large volume conditions (Fig. 6). However, as in small vol- 
ume cultures, the rate of egression of MP  from IL-treated 
cultures  incubated  under  large  volume  conditions  was 
more rapid in the first few hours than at later times (Fig. 6). 
To examine whether the reduced kinetics of egression in 
large volume cultures resulted from a  shear stress response 
induced by the nonstatic environment or whether the dilu- 
tion itself could account for the slower exit of monocytes, 
these  experiments were  repeated as  described except that 
the medium bathing the suspended cultures was not stirred. 
The  results obtained from this approach were  identical to 
the  experiments in which  stirring was  included  (data  not 
shown). Therefore, the decreased rate of basal to apical mi- 
gration of monocytes  across endothelium in large volume 
cultures appears to result from dilution of a soluble media- 
tor(s). 
Role of  Adhesion Molecules in Egression of MP  from HUVEC/ 
Amnion Cultures.  To  explore  the  mechanism  by  which 
MP  traverse  endothelium  in the basal to  apical direction, 
the role of adhesion molecules was investigated. First, we 
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Figure  6.  Effect of dilution  on  the  kinetics of MP  egression from 
HUVEC/amnion  cultures. Monocytes were  incubated with  untreated 
(open symbols) or IL-l-stimulated (filled  symbols) HUVEC/amnion  cultures 
for 2 h. Some cultures (A, A) were then suspended from stainless steel 
hooks in a beaker containing 0.5-1.0 liter (large volume) of stirring me- 
dium and incubated for an additional 22 or 46 h. For comparison, other 
MP-HUVEC cocultures ([2, I) were incubated for an additional 22 or 
46 h under the conditions used in previous experiments (small volume), 
in which 0.5 ml of fresh medium was placed in the interior and 1.0 ml 
around the exterior of the cultures. Data points represent the means -+--  SD 
from three experiments performed in triplicate. Compared to the number 
of MP beneath the endothelium at 2 h of incubation, the number of MP 
located within the amniotic tissue in 24- and 48-h large or small volume 
cultures was significantly reduced, p <0.001  for each of the conditions 
plotted. The differences between the extent of MP egression from 48-h 
large versus small volume cultures, or between 24- versus 48-h small vol- 
ume cultures, are not significant. 
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known  to  promote  leukocytic  migration  across  endothe- 
lium  in  the  apical  to  basal  direction  were  located  on  the 
basal surface of the endothelium,  where  they might medi- 
ate  basal  to  apical  transmigration  of MP.  It has  been  re- 
ported  previously  that  ICAM-1  is  expressed  on  both  the 
apical and basal surfaces of HUVEC in vitro, but expression 
of VCAM-1  is  limited  to  the  apical  surface  (34).  We 
wished to confirm these results in our model system as well 
as examine the distribution of the cytokine-inducible adhe- 
sion molecule,  E-selectin  (28).  These molecules were mi- 
croscopically visualized in cross sections of IL-l-stimulated 
HUVEC/amnion  cultures  by  indirect  immunofluores- 
cence.  E-selectin was present  on both the apical and basal 
endothehal cell surfaces (Fig. 7  a). As in the previous study 
of Oppenheimer-Marks  et  al.  (34),  staining  for  ICAM-1 
was  also  obesrved  on  all  HUVEC  surfaces  (Fig.  7  b),  but 
VCAM-1  staining  was  most intense  on  the  apical  surface 
(Fig.  7  c).  Thus,  the  locations  of ICAM-1  and E-selectin, 
but not VCAM-1, were consistent with the possibility that 
they might  mediate  basal  to  apical  transmigration  of MP. 
Immunostaining for these molecules was determined to be 
specific  because  similar  dilutions  of isotype-matched  Abs 
(for mAbs) or species-matched sera (for polyclonal antisera) 
did  not  stain  HUVEC.  In  addition,  positive  staining  for 
each  of  the  molecules  was  absent  (for  E-selectin  and 
VCAM-1) or decreased (for ICAM-1) in HUVEC/amnion 
cultures  not  pretreated  with  IL-1  (data  not  shown).  The 
distribution  of these  adhesion molecules on umbilical vein 
endothelium  in  situ  matched  the  observations  made  in 
vitro  (Fig.  8  and data not shown),  negating the possibility 
that the results obtained in vitro are due to a loss in the ca- 
pacity  of HUVEC  to  maintain  apical  and  basal  polarity 
through passage in culture. 
To  test  whether  these  adhesion  molecules  mediated 
egression  of MP  from  HUVEC/anmion  cultures,  Fab  or 
F(ab')z  fragments  of neutralizing  mAb  against  ICAM-1, 
E-selectin,  or VCAM-1  were  added  to  HUVEC/amnion 
cultures  after MP  had  completed  their  migration into  the 
amniotic  matrix.  Immunostaining experiments  using anti- 
E-selectin antisera verified that Abs applied  to the cultures 
as described in Materials and Methods readily gained access 
to  the  basal  surface  of the  endothehum.  Fab  fragments  of 
mAb against ICAM-1  (R6.5) completely blocked egression 
of MP  from  IL-l-treated  HUVEC/amnion  cultures  that 
were incubated with MP for a total of 5 h  (Fig. 9  a),  mAb 
fragments  against VCAM-1  (4B9),  E-selectin  (H18/7),  or 
an irrelevant antigen  (MOPC31c)  had no effect (Fig.  9  a). 
When  incubation  of MP-HUVEC  cocultures  (IL-l-pre- 
treated HUVEC) was extended to 12 h, anti-ICAM-1  Fab 
fragments inhibited basal to apical migration of monocytes 
across endothelium by only 53% (Fig. 9  b), 
Figure  7.  Distribution of adhesion molecules on the apical and basal 
surfaces of HUVEC in vitro. Abs against E-selectin (a), ICAM-1 (b), or 
VCAM-1 (c) were incubated with IL-l~stimulated HUVEC/anmion cul- 
tures. Subsequent incubation with TRITC-conjugated  goat anti-mouse 
or anti-rabbit IgG permitted visualization of the locations of these adhe- 
sion molecules in cross sections of HUVEC/amnion  cultures. (Arrows) 
The basal surfaces of  the HUVEC. Bar, 10 Ixm. 
Figure  8.  Distribution of adhesion molecules on the apical and basal 
surfaces of umbilical vein endothelium in situ. mAb against ICAM-1 (a) 
or VCAM-1 (b)  was incubated with  IL-1--stimulated, intact umbilical 
cords.  Subsequent incubation  wtih  TRITC-conjugated  rabbit anti- 
mouse IgG permitted visualization of the locations of these molecules in 
cross sections of umbilical veins. (Arrows) The basal surface of the venular 
endothelium. Bar, 5 I.tm. 
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Figure  9.  Effect of mAb  fragments against adhesion molecules  or 
MCP-1 on egressinn of MP from HUVEC/amnion  cultures. Monocytes 
were incubated for 2 h with HUVEC/amnion  cultures that had been pre- 
treated with IL-1 for 4 h. Cultures were then fixed or rinsed thoroughly 
in M199 and further incubated for 3 (a) or 10 h (b) in medium lacking Ab 
or medium containing Fab fragments of an irrelevant mAb (MOPC31c, 
two experiments, n =  6) or mAb fragments against ICAM-1 (R.6.5; five 
experiments at 5 h, n =  14; two experiments at 12 h, n =  6), E-selectin 
(H18/7; three experiments, n =  10), VCAM-1  (4B9; three experiments, 
n =  9), CD18 (TS1/18; two experiments, n =  6), or MCP-1  ($101; two 
experiments, n =  6). Levels of endotoxin in all mAb fragment prepara- 
tions were <0.06 endotoxin units (EU)/ml at mAb concentrations used 
in these assays, except MOPC31c,  which contained 0.5 EU/ml. In each 
group, the percentage of MP beneath the HUVEC monolayer was deter- 
mined and compared to the percentage of MP located beneath the endo- 
thelium at 2 h of incubation. (*) Data that are significantly reduced rela- 
tive to no mAb controls, p <0.001. 
IfFab fragments against ICAM-1  inhibited basal to apical 
migration of MP from HUVEC/amnion  cultures by inter- 
feting  with  adhesive  contacts  between  MP  and  the  basal 
surface ofHUVEC,  a mAb that blocks binding to CD18,  a 
subunit  of the  CDlla/CD18  and  CDIlb/CD18  tigands 
for ICAM-1  (35, 36) found on MP  (37), would also be ex- 
pected  to  inhibit  egression  of  MP  from  IL-l-treated 
HUVEC/amnion  cultures.  If,  however,  anti-ICAM-1 
mAb inhibits egression by binding  to ICAM-1  on the sur- 
face of MP  (38), mAb against CD11/CD18  should have no 
effect. When  tested in the assay, anti-CD18  Fab fragments 
(TS1/18)  suppressed egression by an average of 71% at 5  h 
of incubation  (Fig.  9  a).  To  ensure  that  anti-CD18  mAb 
did not simply inhibit the movement of MP through extra- 
cellular  matrix  and  thereby  impede  egression,  we  tested 
whether TS1/18  Fab fragments inhibited monocytic bind- 
ing to and migration within amniotic matrix lacking endo- 
thelium in response to 20 nM recombinant human MCP-1 
placed  beneath  the  amnion.  No  difference  in  the  number 
or depth of penetration into the amnion of monocytes was 
observed in the  presence  or absence  of 40  ~g/ml  of anti- 
CD18  Fab fragments in a 2-h assay (data not shown). 
In other control experiments,  media from anti-ICAM-1 
or anti-CD18-treated  HUVEC  amnion cultures were col- 
lected  at  the  end  of the  experiments  measuring  egression 
and were used  in  assays  measuring  transmigration  of neu- 
trophils. The media inhibited transmigration of neutrophils 
in response to FMLP to the same degree as observed previ- 
ously by fully saturating amounts of these Abs (39), indicat- 
ing  that  anti-ICAM-1  and  anti-CD18  Fab  fragments  re- 
mained saturating throughout the MP egression assays  (data 
not shown). 
Investigation  of the Role of MCP-1.  We  also  employed 
neutralizing mAbs to explore the role of MCP-1  in exit of 
MP  from  HUVEC/ammon  cultures.  MCP-1  has  been 
identified previously in MP/HUVEC  cocultures, and it ac- 
counts for all of the soluble chemotactic activity for mono- 
cytes produced  by  these  cultures  (23).  Although  it  is  not 
present in a gradient that would be expected to guide  MP 
across endothelium in the basal to apical direction  (23), we 
aimed  to  determine  whether  the  chemokinetic  activity  of 
MCP-1  (40,  41)  might mediate  egression.  However,  anti- 
MCP-1  Fab  fragments  did not impede  the  exit of mono- 
cytes  from  HUVEC/ammon  cultures  (Fig.  9  a).  Control 
experiments demonstrated that Fab fragments of antibodies 
to  MCP-1  remained  saturating  during  these  experiments 
because  enough  Ab  was present  in  the  medium  collected 
from the cultures at the end of these experiments to inhibit 
all  endogenous  chemotactic  activity  for  monocytes  in  a 
subsequent  blind-well  chamber chemotaxis  assay  (data not 
shown). 
Discussion 
In the present study, we have examined the trafficking of 
MP  across endothelial  monolayers using an in vitro model 
of a blood vessel wall. In this model, freshly isolated human 
458  Basal to Apical Transendothelial  Migration  of Mononuclear Phagocytes monocytes  traverse  unstimulated  and  IL-l-stimulated 
HUVEC  monolayers  to  enter  underlying  amniotic  con- 
nective  tissue  (20).  As  demonstrated  here,  a  majority  of 
the transmigrated MP later exit the amniotic tissue by mi- 
grating back across the  endothelium in the basal to  apical 
direction. 
Potential Physiologic Significance of Basal to Apical  Transen- 
dothetial Migration of MP.  Reports ofmacrophages emerg- 
ing from atherosclerotic lesions support the possibility that 
the  data presented  here are physiologically relevant,  since 
such studies demonstrate that MP can traverse vascular en- 
dothelium  in  the  abluminal to  luminal  direction  in  vivo. 
Electron micrographs of arteries from hypercholesterolemic 
animals  strongly  imply that  monocyte-derived foam cells 
egress from early atherosclerotic lesions by migrating across 
intact,  overlying  endothelium  to  reenter  the  circulation 
(13-15). In addition, degenerate foam cells are found in the 
circulation,  and in liver and spleen, where they are appar- 
ently destroyed  (13).  These observations form the basis  of 
the hypothesis that entrance  of monocytes into  early ath- 
erosclerotic  lesions  serves  the  purpose  of removing lipid 
from the lesions via intravasating macrophages, and that in- 
efficient removal of lipid from early atherosclerotic lesions 
contributes  to  its  progression  to  more severe stages.  Effi- 
cient removal of lipid by macrophages, on the other hand, 
would theoretically lead to regression of the lesion (13). 
The data presented here suggest that exodus from tissues 
by basal to apical migration across endothelium may be a 
normal activity of MP. Whereas the studies of arheroscle- 
rosis strongly suggest that MP  can be cleared from tissues 
by direct  reentrance  into  the  bloodstream,  they  offer no 
quantitative information about the process. Our data, dem- 
onstrating that  >80%  of MP  that migrate into  HUVEC/ 
amnion cultures eventually egress by migrating back across 
the  overlying  endothelium,  suggest  that  the  extent  to 
which  MP  may use  such  a  mechanism  to  exit  tissues  in 
vivo would be quantitatively significant. 
We observed that egression of MP occurred in a diluting 
environment,  as would be found in flowing blood.  These 
results eliminate the possibility that egression of MP from 
HUVEC/amnion cultures is mediated by a strictly soluble 
chemoattractant  that  aberrantly accumulates  in  the  apical 
compartment of the static cultures. Moreover, the only sol- 
uble  chemoattractant  for  monocytes  that  is  detected  in 
MP-HUVEC cocultures is MCP-1  (23),  and the data pre- 
sented here indicate that it does not mediate egression. 
In  the  large  volume  experiments,  only  20%  of  MP 
emerged from either unstimulated or IL-l-treated HUVEC/ 
ammon cultures before 24 h  of incubation, but as many as 
40% exited the cultures by 48 h. These kinetics do not dif- 
fer greatly from those of clearance of MP from experimen- 
tally induced, sterile inflammatory lesions. For example, af- 
ter instillation of glycogen into rat lungs, the accumulation 
ofmononuclear cells in the pleural cavity is also reduced by 
r  at 48 h relative to a maximal accumulation by 12-18 h 
(3).  It is interesting to note that descriptions of the resolu- 
tion of inflammatory lesions are remarkably consistent with 
the possibility that  clearance  of at least some of the  mac- 
rophages occurred by their direct reentrance into the blood- 
stream: 
At 3 days after injection  . . . the numbers  of mononuclear 
cells have diminished as compared with 48 hours. In spite of 
the absence of emigration, many small vessels are surrounded 
by a zone of mononuclear cells. Almost all of these cells have 
in varying degrees undergone [differentiative] changes, indi- 
cating that some time has elapsed since they left the circula- 
tion  ....  Very rarely, one such mononuclear cell is visible 
trapped within the vessel wall. (5) 
Certainly,  in  vivo  studies  to  determine  whether  MP 
traverse endothelium in the abluminal to luminal direction 
during resolution of acute  or chronic inflammation are in 
order. If  physiologic, the imphcations of our observations may 
go beyond explaining how MP normally traffic in the body. 
The  mechanism  of egression  may  also  lend  insight  into 
how tumor cells intravasate during metastasis, illuminate a 
means by which microorganisms disseminate from organ to 
organ, and contribute to a more complete understanding of 
graft rejection.  With regard to the latter,  Ia  + cells migrate 
from myocardial tissue  of donor  hearts  to  the  spleens  of 
transplant recipients  (42),  but the route by which this mi- 
gration occurs is unknown. It is interesting to note that one 
subset of Ia  + cells,  the dendritic cells, is found in the blood 
in  two  distinct  forms--immature dendritic  precursors de- 
rived  from bone  marrow  and  mature  dendritic  cells  that 
bear a phenotype resembhng dendritic  cells  found within 
tissues (43). Perhaps these mature dendritic cells have gained 
access to the blood by reverse transendothelial migration. 
Since  migration  of MP  across vascular endothelium  in 
the abluminal to luminal direction in vivo has yet to be de- 
scribed definitively under circumstances other than within 
atherosclerotic plaques, alternative explanations for our data 
must be considered.  First,  because cultured vascular endo- 
thetium may be similar to lymphatic endothehum, we may 
be modehng how MP exit tissues via the lymphatics. Alter- 
natively, we may have observed basal to apical migration of 
MP  across endothelium  in  HUVEC/amnion  cultures  be- 
cause they lack molecular components that normally retain 
MP within tissues.  Such components could be extracellular 
matrix molecules or may be produced by interstitial fibro- 
blasts,  pericytes,  smooth  muscle  cells,  resident  macro- 
phages, or other leukocytes. 
Mechanism of Egression of MP  from HUVEC /Amnion  Cul- 
tures.  The  rate  at  which  MP  exited  HUVEC/amnion 
cultures decreased when the cultures were placed in a di- 
luting environment, suggesting that a soluble factor(s) me- 
diates the  exodus  of MP from HUVEC/anmion  cultures. 
In  comparison,  the  initial  rate  at  which  MP  egress from 
HUVEC/amnion  cultures  was  increased  by pretreatment 
of the endothelium with IL-1. This increased rate is likely 
due  to upregulation  of ICAM-1  on HUVEC  in response 
to IL-1 (44).  Supporting this hypothesis, in the presence of 
anti-ICAM-1  Fab fragments, the kinetics of egression pre- 
cisely mirror the kinetics of basal to apical transendothelial 
migration of MP from unstimulated HUVEC/anmion cul- 
459  Randolph and Furie tures.  Beyond  accelerating the  initial kinetics,  the  role  of 
ICAM-1 in mediating basal to apical transmigration is un- 
clear. These data suggest that after 5 h  of incubation, other 
molecules, perhaps  along with  ICAM-1,  mediate basal to 
apical migration of MP across endothelium. 
Anti-ICAM-1 mAb appears to block binding of MP  to 
the basal surface of the endothelium, as opposed to interfer- 
ing with the action oflCAM-1  on the surface of MP them- 
selves. Since CDll/CD18  is present on MP, but not endo- 
thelium (36),  data indicating that anti-CD18  mAb inhibits 
basal to apical transendothelial migration of MP imply that 
MP  use  CD11/CD18  integrins to  ligate ICAM-1  on  en- 
dothelium while  exiting  HUVEC/amnion  cultures.  That 
anti-CD18  Fab fragments had no  effect on the interaction 
of monocytes with amniotic matrix counters the caveat to 
this  conclusion  that  the  inhibitory  effect  of  anti-CD18 
mAb may have been because CDll/CD18  integrins were 
necessary for movement of MP through matrix. CD11/18 
integrins on PMN bind to extracellular matrix molecules in 
vitro  (45,  46)  and  mediate  chemotaxis  through  mi- 
croporous filters (47), but they do not seem to be essential 
for MP to bind to extracellular matrix in our cultures. 
Complete abrogation of egression for any length of time 
by addition of Abs to  a  single adhesion molecule such  as 
ICAM-1 is surprising, since monocytes use multiple adhe- 
sive pathways to cross endothelium in the apical to basal di- 
rection.  Specifically,  monocytes  can  use  either  CDll/ 
CD18 or very late antigen 4 to migrate across endothelium 
when initially entering vessel wall constructs (20), and very 
late antigen 4  and CD11/CD18  can each pair with two or 
more distinct endothelial ligands in this process (48). These 
pathways must be blocked simultaneously to  produce  any 
inhibitory effects on transmigration. In contrast to our find- 
ing that Fab fragments of the anti-ICAM-1 Ab P,6.5  com- 
pletely inhibited exit  of MP  from  HUVEC/amnion  cul- 
tures, the same preparation of R6.5 had no inhibitory effect 
on the entrance of monocytes into the cultures (48). These 
data and the finding that MCP-1  is not essential for egres- 
sion of MP  from HUVEC/amnion  cultures,  even  though 
this chemoattractant mediates the initial migration of mono- 
cytes across HUVEC  monolayers (23), clearly illustrate that 
basal to apical transendothelial migration is not simply a re- 
versal of the same events that promote apical to basal trans- 
migration. 
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